How is the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A today?

The Bio-Rad Laboratories Inc. - Ordinary Shares - Class A today is trading in the green, up by 3.87% at 241.56.

How has Bio-Rad Laboratories Inc. - Ordinary Shares - Class A performed historically?

The Bio-Rad Laboratories Inc. - Ordinary Shares - Class A is currently trading up 3.87% on an intraday basis in the past week the index fell -1.03%. The index has been down -29.40% in the past quarter and fell -13.70% in the past year. You can view this in the overview section.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Annual Revenue?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Annual Revenue fell 3.92%, in the last year to $2,566.5 M. Its sector's average revenue growth for the last fiscal year was 8.17%.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Annual Net Profit?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Annual Net Profit fell 189.38% in the last year to $1,844.2 M. Its sector's average net profit growth for the last fiscal year was 4.92%.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Price to Earning Ratio?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Price to Earning Ratio is -3.04, which is negative.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Stock Price?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Stock Price fell 13.7% and underperformed its sector by 23.45% in the past year.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Quarterly Revenue?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Quarterly Revenue fell 4.16% YoY to $585.4 M. Its sector's average revenue growth YoY for the quarter was 8.33%.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Quarterly Net profit?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Quarterly Net profit fell 83.33% YoY to $64 M. Its sector's average net profit growth YoY for the quarter was -11.02%.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Debt to Equity Ratio?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Debt to Equity Ratio of 0.21 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Return on Equity(ROE)?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was -24.09%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Mutual Fund Holding?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Mutual Fund Holding decreased by 0.21% in the last quarter to 58.11.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Promoter Share Holding?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Promoter Share Holding increased by 0.01% in the most recent quarter to 3.38%.

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Interest Coverage Ratio?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Interest Coverage Ratio is -46.9, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Institutional Holding?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Institutional Holding decreased by 0.34% in the last quarter to 72.6.

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A XNYS: BIO

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Bio-Rad Laboratories Inc. - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
Rating: 1.603874875
Author: Trendlyne DVM scores

Weak Stock

about

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and speci...

241.56 9.01 (3.87%)

37.74% Fall from 52W High

145.1K XNYS Volume

XNYS 08 May, 2025 3:00 PM (EDT)

Low Financial Strength

33.3 / 100

Mid Valuation

33.8 / 100

Technically Bearish

27.8 / 100

Weak Stock These stocks are the ones with poor quality and weak financial and technical aspects. However, these stocks have a medium valuation score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

319

1Yr Price target upside is 32%

6 analysts

Bio-Rad Laboratories Inc. ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and speci...

37.74% Fall from 52W High

SWOT Analysis

Bio-Rad Laboratories Inc. ... Live Price Chart

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A FAQ

How is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A today?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A today is trading in the green, and is up by 3.87% at 241.56.

How has Bio-Rad Laboratories Inc. - Ordinary Shares - Class A performed historically?

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A is currently trading up 3.87% on an intraday basis. In the past week the stock fell -1.03%. stock has been down -29.40% in the past quarter and fell -13.70% in the past year. You can view this in the overview section.